Clinical Trials Sponsored by ActiveLife Scientific

Total 1987 results

Boston Scientific Corporation

Completed

Registry on WATCHMAN Outcomes in Real-Life Utilization (EWOLUTION)

Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke

Ireland, Spain, Germany, Netherlands, France, United Kingdom, Italy, Russian Federation, Portugal, Belgium, Poland, Saudi Arabia, United Arab Emirates
Boston Scientific Corporation

Completed

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions (PLATINUM)

Coronary Artery Disease

United States, Denmark, Australia, Germany, Belgium, Finland, Netherlands, New Zealand, France, United Kingdom, Malaysia, Japan, Singapore, Poland, Latvia, Austria, Portugal
Boston Scientific Corporation

Completed

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL) (PLATINUM LL)

Coronary Artery Disease

United States, Australia, Latvia, Belgium, France, New Zealand, Japan
Boston Scientific Corporation

Completed

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels (PLATINUM SV)

Coronary Artery Disease

United States, Australia, France, Belgium, New Zealand, Japan
Boston Scientific Corporation

Completed

Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy (MIRACLEIII)

Colorectal Carcinoma

Italy
Boston Scientific Corporation

Completed

Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME)

Peripheral Arterial Disease

Japan
Boston Scientific Corporation

Completed

Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation (ZERO-AF)

Paroxysmal Atrial Fibrillation (PAF)

United States, Spain, Germany, Australia, United Kingdom, Sweden, Czechia, France, Portugal
Boston Scientific Corporation

Completed

Self-Centering Guide Catheter Feasibility Study

Aortic Stenosis

United States
Boston Scientific Corporation

Completed

SpyGlass Direct Visualization System Clinical Registry in China (SpyChina)

Biliary Tract Diseases

China
Boston Scientific Corporation

Completed

PROMUS Element Plus US Post-Approval Study

Coronary Artery Disease

United States
Boston Scientific Corporation

Completed

Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy (PREVAIL)

Stroke | Atrial Fibrillation

United States
Boston Scientific Corporation

Completed

Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter (BLOCk-CTI)

Atrial Flutter

United States
Boston Scientific Corporation

Completed

The Captivator EMR Registry

Barrett's Esophagus

United States, Canada, Belgium, United Kingdom, Netherlands, Germany
Boston Scientific Corporation

Completed

Prospective Registry on User Experience With The Mapping System For Ablation Procedures (TRUE-HD)

Cardiac Arrhythmias

United States, Netherlands, Hong Kong, France, Spain, Germany, Australia, United Kingdom
Boston Scientific Corporation

Completed

ChOcolate COnsumption And Blood Pressure (COCOA-BP): A Wearable Devices Pilot Trial (COCOA-BP)

Blood Pressure | Health Behavior
Boston Scientific Corporation

Completed

REASSURE AV Registry (REASSURE)

Bradycardia | Sudden Cardiac Death

United States
Boston Scientific Corporation

Terminated

Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction (RESET)

Heart Failure

United States
Boston Scientific Corporation

Completed

IntellaTip MiFi XP Ablation Catheter Trial (MiFi-CTI)

Atrial Flutter

Australia
Boston Scientific Corporation

Completed

A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions (TAXUS VI)

Coronary Artery Disease

Germany
Boston Scientific Corporation

Completed

The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study

Post Myocardial Infarction

United States
Boston Scientific Corporation

Completed

TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients (TRADE HF)

Heart Failure, Congestive

Italy
Boston Scientific Corporation

Completed

SuperNOVA Clinical Stenting Trial

Atherosclerosis of Native Arteries of the Extremities, Unspecified

Belgium, United States, United Kingdom, Japan, Austria, Canada, Germany
Boston Scientific Corporation

Withdrawn

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases (Prometheus)

Liver Neoplasm | Metastatic Liver Cancer | Secondary Liver Cancer

United States
Boston Scientific Corporation

Completed

OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator

Ventricular Fibrillation | Ventricular Tachycardia

France
Boston Scientific Corporation

Completed

Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal (PAPIRUSII)

Heart Failure
Boston Scientific Corporation

Completed

Electrocardiogram (ECG) Recordings in Paediatric Population

Arrhythmia

United Kingdom
Boston Scientific Corporation

Completed

Decompensation Detection Study

Heart Failure
Boston Scientific Corporation

Completed

REFLEx Study (ENDOTAK RELIANCE G Evaluation of Handling and Electrical Performance

Arrhythmia
Boston Scientific Corporation

Completed

Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications (OPTI-MIND)

Bradyarrhythmia

Germany
Boston Scientific Corporation

Completed

The Jetstream (JET) Post-market Registry (JET)

Peripheral Arterial Diseases

United States
Boston Scientific Corporation

Completed

The Jetstream G3™ Calcium Study

Peripheral Arterial Disease

United States
Boston Scientific Corporation

Withdrawn

The Boston Scientific ENOVUS Trial

Abdominal Aortic Aneurysm
Boston Scientific Corporation

Completed

The ACE Follow-up Study

Obesity

Netherlands, Argentina, Canada, Israel
Boston Scientific Corporation

Completed

WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation

Stroke | Atrial Fibrillation

United States, Czech Republic, Germany
Boston Scientific Corporation

Completed

EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries (ORION)

Iliac Artery Stenosis

United States
Boston Scientific Corporation

Completed

High Rate Spinal Cord Stimulation (SCS) for Chronic Pain

Chronic Pain

United States
Boston Scientific Corporation

Completed

An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence

Urinary Incontinence

United States
Boston Scientific Corporation

Completed

Comparison of AV Optimization Methods Used in Cardiac Resynchronization Therapy (CRT) (SMART-AV)

Heart Failure

United States
Boston Scientific Corporation

Completed

Physiological Response to Exercise: Sensor Evaluation at Specified Exertions (PRE-SENSE)

Heart Failure

United States
Boston Scientific Corporation

Completed

Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions

Coronary Artery Disease

United States, Singapore, New Zealand, Taiwan
Boston Scientific Corporation

Completed

RIGHT: Rhythm ID Going Head-to-Head Trial

Tachycardia

United States
Polymun Scientific GmbH

Completed

Comparative Pharmacokinetics of AFOLIA and Gonal-f® After Single Subcutaneous Application

Healthy
Boston Scientific Corporation

Terminated

Correlation Of Respiratory Rate Level And Trend Evaluation in Heart Failure Patients (CORRELATE-HF)

Heart Failure

Belgium, United States
Kalaco Scientific, Inc.

Completed

Nexalin Therapy for the Treatment of Depressive Symptoms

Depression

Russian Federation
Boston Scientific Corporation

Completed

Safety and Efficacy Study of RENEWAL 4 AVT

Heart Failure | Atrial Fibrillation | Ventricular Fibrillation | Tachycardia | Atrial Flutter

Germany
Boston Scientific Corporation

Completed

Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF

Congestive Heart Failure

United States
Boston Scientific Corporation

Completed

Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation

Ventricular Fibrillation | Tachycardia, Ventricular | Heart Failure, Congestive

United States
Boston Scientific Corporation

Not yet recruiting

SpaceIT Hydrogel System for Perirectal Spacing (HYDROSPACE)

Prostate Cancer
Boston Scientific Corporation

Not yet recruiting

Obsidio™ Conformable Embolic Registry (OCCLUDE)

Hemorrhage | Bleeding | Hypervascular Tumors
Boston Scientific Corporation

Recruiting

SpyGlass Surgical Study

Pancreatic Diseases | Bile Duct Diseases | Hepatic Disease

United States, India, China, Hong Kong

Clinical Trials Sponsored by ActiveLife Scientific

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations